ロード中...
Gemcitabine and capecitabine for advanced biliary cancer
BACKGROUND: Gemcitabine with capecitabine (gem-cap) is an established regimen for advanced biliary cancer (ABC) supported by our previously reported phase II trial. Here, we provide our updated experience. METHODS: Single institution, retrospective study from 2005 to 2015 of ABC treated with gem-cap...
保存先:
| 出版年: | J Gastrointest Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5582046/ https://ncbi.nlm.nih.gov/pubmed/28890824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.01.24 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|